|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1987-10-15
|
|
pubmed:abstractText |
After primary immunization with adsorbed DPT vaccine antitetanus immunity was retained for 9-10 years in 90.6-98.4% of children covered by this study. The second booster immunization of children against tetanus with adsorbed DT toxoid with reduced antigen content, made at an interval prolonged to 7-10 years under the conditions of lower antitoxic immunity, ensured a high level of intense antitetanus immunity. These data point to the possibility of prolonging the interval between booster immunizations to 9-10 years and reducing the number of injections and antigenic load.
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0372-9311
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
43-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:3307239-Adolescent,
pubmed-meshheading:3307239-Antibodies, Bacterial,
pubmed-meshheading:3307239-Child,
pubmed-meshheading:3307239-Clostridium tetani,
pubmed-meshheading:3307239-Diphtheria,
pubmed-meshheading:3307239-Diphtheria Toxoid,
pubmed-meshheading:3307239-Diphtheria-Tetanus-Pertussis Vaccine,
pubmed-meshheading:3307239-Drug Combinations,
pubmed-meshheading:3307239-Drug Evaluation,
pubmed-meshheading:3307239-Humans,
pubmed-meshheading:3307239-Immunization, Secondary,
pubmed-meshheading:3307239-Pertussis Vaccine,
pubmed-meshheading:3307239-Tetanus,
pubmed-meshheading:3307239-Tetanus Toxoid,
pubmed-meshheading:3307239-Time Factors
|
|
pubmed:year |
1987
|
|
pubmed:articleTitle |
[Immunological effectiveness of secondary revaccination against tetanus performed at prolonged intervals].
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|
